Site Map
Product Pages Catalogue Numbers 1001 - 1100
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 1001 | Chlorisondamine diiodide |
Nicotinic antagonist; slow offset |
|
| 1002 | L-745,870 trihydrochloride |
Highly selective D4 antagonist |
|
| 1003 | L-741,626 |
High affinity D2 antagonist |
|
| 1004 | L-741,742 hydrochloride |
Highly selective D4 antagonist |
|
| 1006 | BMY 7378 dihydrochloride |
| Selective α1D antagonist, 5-HT1A partial agonist | |
| 1007 | N-Desmethylclozapine |
| 5-HT2C antagonist | |
| 1008 | SNC 121 |
| Potent analogue of Cat. No. 0764 | |
| 1009 | E4CPG |
| Group I/group II mGlu antagonist | |
| 1014 | QX 314 bromide |
| Na+ channel blocker | |
| 1015 | RS 16566 dihydrochloride |
| 5-HT3 ligand. Also shows affinity for zacopride binding site | |
| 1017 | Anandamide (in TocrisolveTM 100) |
Endogenous CB receptor agonist (in water-soluble emulsion) |
|
| 1018 | LY 225910 |
| Potent CCK2 antagonist | |
| 1019 | LY 235959 |
| Competitive NMDA antagonist | |
| 1024 | CGP 20712 dihydrochloride |
Highly potent and selective β1 antagonist |
|
| 1025 | Nisoxetine hydrochloride |
Noradrenaline re-uptake inhibitor |
|
| 1026 | HomoAMPA |
| Potent, highly selective mGlu6 agonist | |
| 1027 | PHCCC |
| Potent group I mGlu antagonist | |
| 1028 | CPCCOEt |
| Selective non-competitive mGlu1 receptor antagonist | |
| 1029 | Methyllycaconitine citrate |
α7 neuronal nicotinic receptor antagonist |
|
| 1030 | Guanfacine hydrochloride |
α2A agonist |
|
| 1031 | Piribedil hydrochloride |
Dopamine agonist |
|
| 1032 | CP 93129 dihydrochloride |
| 5-HT1B agonist | |
| 1033 | Fluvoxamine maleate |
| 5-HT re-uptake inhibitor | |
| 1034 | 4-P-PDOT |
| MT2 antagonist | |
| 1035 | 8-M-PDOT |
| Melatonin agonist | |
| 1036 | ZM 241385 |
| Potent, highly selective A2A antagonist | |
| 1037 | PD 153035 hydrochloride |
| EGFR-kinase inhibitor | |
| 1038 | WIN 55,212-2 mesylate |
Highly potent cannabinoid agonist |
|
| 1040 | TPMPA |
| Selective GABAC antagonist | |
| 1041 | 1-EBIO |
| Activator of epithelial Kca channels | |
| 1042 | N-Methyllidocaine iodide |
| Enhances biosynthesis of phosphatidylinositol | |
| 1043 | QX 222 |
| Na+ channel blocker | |
| 1044 | NBQX disodium salt |
| More water soluble form of (0373) | |
| 1045 | CNQX disodium salt |
| More water soluble form of (0190) | |
| 1046 | Zardaverine |
| PDE3/4 inhibitor | |
| 1047 | ICI 182,780 |
| Estrogen receptor antagonist | |
| 1048 | 1-BCP |
| Modulates AMPA-mediated responses | |
| 1049 | CHPG |
| mGlu5 selective agonist | |
| 1050 | RS 102221 hydrochloride |
| Selective 5-HT2C antagonist | |
| 1051 | Zinterol hydrochloride |
| Selective β2 agonist | |
| 1052 | A 61603 hydrobromide |
| α1A agonist | |
| 1053 | RJR 2403 fumarate |
CNS selective nicotinic agonist |
|
| 1054 | GR 55562 dihydrochloride |
| 5-HT1B antagonist | |
| 1055 | Endomorphin-1 |
| Potent and selective μ agonist | |
| 1056 | Endomorphin-2 |
| Potent and selective μ agonist | |
| 1057 | WIN 64338 hydrochloride |
| Bradykinin B2 antagonist | |
| 1058 | L-3'-F2CCG-I |
| Potent group I/group II agonist | |
| 1059 | BW 723C86 hydrochloride |
| 5-HT2B agonist | |
| 1060 | (S)-(-)-Pindolol |
More active enantiomer |
|
| 1061 | (-)-Quinpirole hydrochloride |
Selective D2-like agonist |
|
| 1062 | 2-Methylthioadenosine triphosphate tetrasodium salt |
| P2 purinergic agonist | |
| 1063 | CGS 21680 hydrochloride |
| A2A agonist | |
| 1064 | Methysergide maleate |
| 5-HT1/5-HT2 antagonist | |
| 1065 | PD 168077 maleate |
High affinity, selective D4 agonist |
|
| 1066 | IB-MECA |
| A3 selective agonist | |
| 1067 | Oxotremorine M |
Muscarinic agonist |
|
| 1068 | Senktide |
| Tachykinin NK3 agonist | |
| 1069 | Tetrodotoxin citrate |
| Citrate salt of Cat. No. 1078 | |
| 1070 | Zolantidine dimaleate |
| Potent, centrally active H2 antagonist | |
| 1071 | Pirenzepine dihydrochloride |
Selective M1 muscarinic antagonist |
|
| 1072 | AGN 192403 hydrochloride |
| I1 selective ligand | |
| 1073 | (RS)-APICA |
| Selective group II antagonist | |
| 1074 | (RS)-AMPA hydrobromide |
| More water soluble form of Cat. No. 0169 | |
| 1075 | Nifedipine |
| Ca2+ channel blocker (L-type) | |
| 1076 | Ouabain |
| Na+,K+-ATPase inhibitor | |
| 1077 | (-)-Lobeline hydrochloride |
Nicotinic agonist |
|
| 1078 | Tetrodotoxin |
| Na+ channel blocker | |
| 1079 | (+)-SK&F 10047 hydrochloride |
| σ1 selective agonist | |
| 1080 | (R)-(+)-8-Hydroxy-DPAT hydrobromide |
| More active enantiomer | |
| 1081 | SKF 89976A hydrochloride |
| Potent GABA uptake inhibitor. Penetrates blood brain barrier | |
| 1082 | CFM-2 |
| Non-competitive AMPA antagonist | |
| 1084 | ω-Conotoxin MVIIC |
| Ca2+ channel blocker (N, P and Q-type) | |
| 1085 | ω-Conotoxin GVIA |
| Ca2+ channel blocker (N-type) | |
| 1086 | Iberiotoxin |
| K+ channel blocker (high conductance, Ca2+-dependent) | |
| 1087 | Charybdotoxin |
| K+ channel blocker (high conductance, Ca2+-dependent) | |
| 1088 | CGP 54626 hydrochloride |
| Potent, selective GABAB antagonist | |
| 1089 | 8-Bromo-cGMP, sodium salt |
| cGMP analogue | |
| 1091 | BU 226 hydrochloride |
| Potent, highly selective I2 ligand | |
| 1092 | [Phe1Y(CH2-NH)Gly2]Nociceptin(1-13)NH2 |
| Selective nociceptin agonist | |
| 1093 | Pirfenidone |
| Antifibrotic agent; regulates cytokine levels in vivo | |
| 1094 | Zopiclone |
| Benzodiazepine agonist | |
| 1095 | (R)-(-)-Deprenyl hydrochloride |
| MAO-B inhibitor | |
| 1097 | Taxol |
| Promotes assembly and inhibits disassembly of microtubules | |
| 1098 | Tranilast |
| Anti-allergic, inhibits release from mast cells | |
| 1099 | Forskolin |
| Adenylyl cyclase activator | |
| 1100 | Camptothecin |
| DNA topoisomerase inhibitor | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]